Laboratory Corporation of America (NYSE:LH) Holdings, widely known as LabCorp, has reached a new 52-week high, with its stock price soaring to $239.65. This milestone reflects a significant uptrend in the company's market performance, marking a robust 16.33% increase in value over the past year. Investors have shown growing confidence in LabCorp, a leading global life sciences company, as it continues to expand its diagnostics and drug development services. The 52-week high represents a culmination of sustained growth, reinforcing LabCorp's strong position in the healthcare sector.
In other recent news, Labcorp Holdings has reported a 7% year-over-year increase in revenue to $3.3 billion in its Q3 2024 earnings call. The company's diagnostics revenue grew by 9%, while biopharma laboratory services rose by 3%. Adjusted earnings per share (EPS) were up by 4% at $3.50. Despite the impact of Hurricanes Helene and Milton, Labcorp maintained a positive outlook, buoyed by strategic acquisitions and the introduction of new products. Adjustments to operating income and margin were noted, alongside a robust business development pipeline and expected savings from the LaunchPad initiative. Labcorp anticipates enterprise revenue growth of 6.6% to 7.3% for 2024 and adjusted EPS guidance is set between $14.30 and $14.70. The company's future expectations include margin improvements in the second half of the next year following the integration of Invitae (OTC:NVTAQ). These are some of the recent developments for Labcorp Holdings.
InvestingPro Insights
LabCorp's recent achievement of a 52-week high is further supported by several key metrics and insights from InvestingPro. The company's stock has been trading near its 52-week high, which aligns with the article's main focus. Additionally, InvestingPro data reveals that LabCorp has been profitable over the last twelve months, and analysts predict continued profitability for the current year.
An InvestingPro Tip highlights that LabCorp is a prominent player in the Healthcare Providers & Services industry, which reinforces its strong market position mentioned in the article. Another valuable InvestingPro Tip indicates that the stock generally trades with low price volatility, suggesting stability in its upward trajectory.
For investors seeking a more comprehensive analysis, InvestingPro offers 5 additional tips that could provide further insights into LabCorp's financial health and market prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.